nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Epirubicin—testicular cancer	0.322	0.433	CbGbCtD
Moxifloxacin—TOP2A—Etoposide—testicular cancer	0.251	0.337	CbGbCtD
Moxifloxacin—TOP2A—Doxorubicin—testicular cancer	0.171	0.23	CbGbCtD
Moxifloxacin—TOP2A—Vindesine—Vinblastine—testicular cancer	0.00121	0.188	CbGdCrCtD
Moxifloxacin—TOP2A—Vinorelbine—Vinblastine—testicular cancer	0.000766	0.118	CbGdCrCtD
Moxifloxacin—TOP2A—Podofilox—Etoposide—testicular cancer	0.000765	0.118	CbGdCrCtD
Moxifloxacin—TOP2A—Teniposide—Etoposide—testicular cancer	0.000765	0.118	CbGdCrCtD
Moxifloxacin—TOP2A—Vincristine—Vinblastine—testicular cancer	0.000655	0.101	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Epirubicin—testicular cancer	0.000399	0.0617	CbGdCrCtD
Moxifloxacin—TOP2A—Doxorubicin—Epirubicin—testicular cancer	0.000399	0.0617	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Epirubicin—testicular cancer	0.000399	0.0617	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Doxorubicin—testicular cancer	0.000369	0.0571	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Doxorubicin—testicular cancer	0.000369	0.0571	CbGdCrCtD
Moxifloxacin—TOP2A—Epirubicin—Doxorubicin—testicular cancer	0.000369	0.0571	CbGdCrCtD
Moxifloxacin—Eye disorder—Methotrexate—testicular cancer	9.35e-05	0.000375	CcSEcCtD
Moxifloxacin—Tinnitus—Methotrexate—testicular cancer	9.33e-05	0.000374	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Epirubicin—testicular cancer	9.31e-05	0.000374	CcSEcCtD
Moxifloxacin—Asthenia—Cisplatin—testicular cancer	9.29e-05	0.000373	CcSEcCtD
Moxifloxacin—Pharyngitis—Epirubicin—testicular cancer	9.29e-05	0.000373	CcSEcCtD
Moxifloxacin—Cardiac disorder—Methotrexate—testicular cancer	9.28e-05	0.000372	CcSEcCtD
Moxifloxacin—Sweating—Doxorubicin—testicular cancer	9.25e-05	0.000371	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Epirubicin—testicular cancer	9.24e-05	0.000371	CcSEcCtD
Moxifloxacin—Oedema peripheral—Epirubicin—testicular cancer	9.22e-05	0.00037	CcSEcCtD
Moxifloxacin—Haematuria—Doxorubicin—testicular cancer	9.2e-05	0.000369	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Epirubicin—testicular cancer	9.2e-05	0.000369	CcSEcCtD
Moxifloxacin—Urethral disorder—Epirubicin—testicular cancer	9.17e-05	0.000368	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Doxorubicin—testicular cancer	9.12e-05	0.000366	CcSEcCtD
Moxifloxacin—Epistaxis—Doxorubicin—testicular cancer	9.1e-05	0.000365	CcSEcCtD
Moxifloxacin—Angiopathy—Methotrexate—testicular cancer	9.07e-05	0.000364	CcSEcCtD
Moxifloxacin—Sinusitis—Doxorubicin—testicular cancer	9.05e-05	0.000363	CcSEcCtD
Moxifloxacin—Immune system disorder—Methotrexate—testicular cancer	9.03e-05	0.000362	CcSEcCtD
Moxifloxacin—Visual impairment—Epirubicin—testicular cancer	9.02e-05	0.000362	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Methotrexate—testicular cancer	9.01e-05	0.000362	CcSEcCtD
Moxifloxacin—Agranulocytosis—Doxorubicin—testicular cancer	9e-05	0.000361	CcSEcCtD
Moxifloxacin—Chills—Methotrexate—testicular cancer	8.97e-05	0.00036	CcSEcCtD
Moxifloxacin—Nausea—Ifosfamide—testicular cancer	8.92e-05	0.000358	CcSEcCtD
Moxifloxacin—Diarrhoea—Cisplatin—testicular cancer	8.86e-05	0.000355	CcSEcCtD
Moxifloxacin—Erythema multiforme—Epirubicin—testicular cancer	8.85e-05	0.000355	CcSEcCtD
Moxifloxacin—Bradycardia—Doxorubicin—testicular cancer	8.82e-05	0.000354	CcSEcCtD
Moxifloxacin—Mental disorder—Methotrexate—testicular cancer	8.76e-05	0.000352	CcSEcCtD
Moxifloxacin—Eye disorder—Epirubicin—testicular cancer	8.75e-05	0.000351	CcSEcCtD
Moxifloxacin—Hypersensitivity—Etoposide—testicular cancer	8.74e-05	0.000351	CcSEcCtD
Moxifloxacin—Tinnitus—Epirubicin—testicular cancer	8.73e-05	0.00035	CcSEcCtD
Moxifloxacin—Malnutrition—Methotrexate—testicular cancer	8.71e-05	0.000349	CcSEcCtD
Moxifloxacin—Erythema—Methotrexate—testicular cancer	8.71e-05	0.000349	CcSEcCtD
Moxifloxacin—Haemoglobin—Doxorubicin—testicular cancer	8.7e-05	0.000349	CcSEcCtD
Moxifloxacin—Cardiac disorder—Epirubicin—testicular cancer	8.69e-05	0.000348	CcSEcCtD
Moxifloxacin—Rhinitis—Doxorubicin—testicular cancer	8.68e-05	0.000348	CcSEcCtD
Moxifloxacin—Haemorrhage—Doxorubicin—testicular cancer	8.66e-05	0.000347	CcSEcCtD
Moxifloxacin—Hepatitis—Doxorubicin—testicular cancer	8.66e-05	0.000347	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Doxorubicin—testicular cancer	8.62e-05	0.000346	CcSEcCtD
Moxifloxacin—Pharyngitis—Doxorubicin—testicular cancer	8.6e-05	0.000345	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Doxorubicin—testicular cancer	8.55e-05	0.000343	CcSEcCtD
Moxifloxacin—Oedema peripheral—Doxorubicin—testicular cancer	8.53e-05	0.000342	CcSEcCtD
Moxifloxacin—Dysgeusia—Methotrexate—testicular cancer	8.53e-05	0.000342	CcSEcCtD
Moxifloxacin—Asthenia—Etoposide—testicular cancer	8.51e-05	0.000341	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Doxorubicin—testicular cancer	8.51e-05	0.000341	CcSEcCtD
Moxifloxacin—Angiopathy—Epirubicin—testicular cancer	8.49e-05	0.000341	CcSEcCtD
Moxifloxacin—Urethral disorder—Doxorubicin—testicular cancer	8.49e-05	0.000341	CcSEcCtD
Moxifloxacin—Immune system disorder—Epirubicin—testicular cancer	8.45e-05	0.000339	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Epirubicin—testicular cancer	8.44e-05	0.000338	CcSEcCtD
Moxifloxacin—Back pain—Methotrexate—testicular cancer	8.42e-05	0.000338	CcSEcCtD
Moxifloxacin—Chills—Epirubicin—testicular cancer	8.4e-05	0.000337	CcSEcCtD
Moxifloxacin—Pruritus—Etoposide—testicular cancer	8.39e-05	0.000337	CcSEcCtD
Moxifloxacin—Arrhythmia—Epirubicin—testicular cancer	8.36e-05	0.000335	CcSEcCtD
Moxifloxacin—Visual impairment—Doxorubicin—testicular cancer	8.35e-05	0.000335	CcSEcCtD
Moxifloxacin—Vomiting—Cisplatin—testicular cancer	8.23e-05	0.00033	CcSEcCtD
Moxifloxacin—Vision blurred—Methotrexate—testicular cancer	8.21e-05	0.000329	CcSEcCtD
Moxifloxacin—Mental disorder—Epirubicin—testicular cancer	8.2e-05	0.000329	CcSEcCtD
Moxifloxacin—Erythema multiforme—Doxorubicin—testicular cancer	8.19e-05	0.000328	CcSEcCtD
Moxifloxacin—Rash—Cisplatin—testicular cancer	8.16e-05	0.000328	CcSEcCtD
Moxifloxacin—Dermatitis—Cisplatin—testicular cancer	8.16e-05	0.000327	CcSEcCtD
Moxifloxacin—Erythema—Epirubicin—testicular cancer	8.15e-05	0.000327	CcSEcCtD
Moxifloxacin—Malnutrition—Epirubicin—testicular cancer	8.15e-05	0.000327	CcSEcCtD
Moxifloxacin—Diarrhoea—Etoposide—testicular cancer	8.12e-05	0.000326	CcSEcCtD
Moxifloxacin—Eye disorder—Doxorubicin—testicular cancer	8.09e-05	0.000325	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Methotrexate—testicular cancer	8.08e-05	0.000324	CcSEcCtD
Moxifloxacin—Tinnitus—Doxorubicin—testicular cancer	8.07e-05	0.000324	CcSEcCtD
Moxifloxacin—Anaemia—Methotrexate—testicular cancer	8.05e-05	0.000323	CcSEcCtD
Moxifloxacin—Cardiac disorder—Doxorubicin—testicular cancer	8.04e-05	0.000322	CcSEcCtD
Moxifloxacin—Flatulence—Epirubicin—testicular cancer	8.03e-05	0.000322	CcSEcCtD
Moxifloxacin—Tension—Epirubicin—testicular cancer	8e-05	0.000321	CcSEcCtD
Moxifloxacin—Dysgeusia—Epirubicin—testicular cancer	7.98e-05	0.00032	CcSEcCtD
Moxifloxacin—Nervousness—Epirubicin—testicular cancer	7.91e-05	0.000317	CcSEcCtD
Moxifloxacin—Back pain—Epirubicin—testicular cancer	7.88e-05	0.000316	CcSEcCtD
Moxifloxacin—Angiopathy—Doxorubicin—testicular cancer	7.86e-05	0.000315	CcSEcCtD
Moxifloxacin—Malaise—Methotrexate—testicular cancer	7.85e-05	0.000315	CcSEcCtD
Moxifloxacin—Dizziness—Etoposide—testicular cancer	7.84e-05	0.000315	CcSEcCtD
Moxifloxacin—Muscle spasms—Epirubicin—testicular cancer	7.83e-05	0.000314	CcSEcCtD
Moxifloxacin—Immune system disorder—Doxorubicin—testicular cancer	7.82e-05	0.000314	CcSEcCtD
Moxifloxacin—Vertigo—Methotrexate—testicular cancer	7.82e-05	0.000314	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Doxorubicin—testicular cancer	7.81e-05	0.000313	CcSEcCtD
Moxifloxacin—Leukopenia—Methotrexate—testicular cancer	7.79e-05	0.000313	CcSEcCtD
Moxifloxacin—Chills—Doxorubicin—testicular cancer	7.77e-05	0.000312	CcSEcCtD
Moxifloxacin—Arrhythmia—Doxorubicin—testicular cancer	7.74e-05	0.00031	CcSEcCtD
Moxifloxacin—Nausea—Cisplatin—testicular cancer	7.69e-05	0.000309	CcSEcCtD
Moxifloxacin—Vision blurred—Epirubicin—testicular cancer	7.68e-05	0.000308	CcSEcCtD
Moxifloxacin—Cough—Methotrexate—testicular cancer	7.6e-05	0.000305	CcSEcCtD
Moxifloxacin—Mental disorder—Doxorubicin—testicular cancer	7.59e-05	0.000304	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Epirubicin—testicular cancer	7.56e-05	0.000303	CcSEcCtD
Moxifloxacin—Convulsion—Methotrexate—testicular cancer	7.54e-05	0.000303	CcSEcCtD
Moxifloxacin—Vomiting—Etoposide—testicular cancer	7.54e-05	0.000303	CcSEcCtD
Moxifloxacin—Malnutrition—Doxorubicin—testicular cancer	7.54e-05	0.000302	CcSEcCtD
Moxifloxacin—Erythema—Doxorubicin—testicular cancer	7.54e-05	0.000302	CcSEcCtD
Moxifloxacin—Anaemia—Epirubicin—testicular cancer	7.53e-05	0.000302	CcSEcCtD
Moxifloxacin—Agitation—Epirubicin—testicular cancer	7.49e-05	0.0003	CcSEcCtD
Moxifloxacin—Rash—Etoposide—testicular cancer	7.48e-05	0.0003	CcSEcCtD
Moxifloxacin—Dermatitis—Etoposide—testicular cancer	7.47e-05	0.0003	CcSEcCtD
Moxifloxacin—Headache—Etoposide—testicular cancer	7.43e-05	0.000298	CcSEcCtD
Moxifloxacin—Flatulence—Doxorubicin—testicular cancer	7.43e-05	0.000298	CcSEcCtD
Moxifloxacin—Chest pain—Methotrexate—testicular cancer	7.41e-05	0.000297	CcSEcCtD
Moxifloxacin—Arthralgia—Methotrexate—testicular cancer	7.41e-05	0.000297	CcSEcCtD
Moxifloxacin—Myalgia—Methotrexate—testicular cancer	7.41e-05	0.000297	CcSEcCtD
Moxifloxacin—Tension—Doxorubicin—testicular cancer	7.4e-05	0.000297	CcSEcCtD
Moxifloxacin—Dysgeusia—Doxorubicin—testicular cancer	7.38e-05	0.000296	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	7.36e-05	0.000295	CcSEcCtD
Moxifloxacin—Malaise—Epirubicin—testicular cancer	7.35e-05	0.000295	CcSEcCtD
Moxifloxacin—Discomfort—Methotrexate—testicular cancer	7.32e-05	0.000294	CcSEcCtD
Moxifloxacin—Nervousness—Doxorubicin—testicular cancer	7.32e-05	0.000294	CcSEcCtD
Moxifloxacin—Vertigo—Epirubicin—testicular cancer	7.32e-05	0.000294	CcSEcCtD
Moxifloxacin—Syncope—Epirubicin—testicular cancer	7.31e-05	0.000293	CcSEcCtD
Moxifloxacin—Leukopenia—Epirubicin—testicular cancer	7.29e-05	0.000293	CcSEcCtD
Moxifloxacin—Back pain—Doxorubicin—testicular cancer	7.29e-05	0.000293	CcSEcCtD
Moxifloxacin—Muscle spasms—Doxorubicin—testicular cancer	7.25e-05	0.000291	CcSEcCtD
Moxifloxacin—Palpitations—Epirubicin—testicular cancer	7.2e-05	0.000289	CcSEcCtD
Moxifloxacin—Confusional state—Methotrexate—testicular cancer	7.16e-05	0.000287	CcSEcCtD
Moxifloxacin—Loss of consciousness—Epirubicin—testicular cancer	7.16e-05	0.000287	CcSEcCtD
Moxifloxacin—Cough—Epirubicin—testicular cancer	7.11e-05	0.000285	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Methotrexate—testicular cancer	7.11e-05	0.000285	CcSEcCtD
Moxifloxacin—Vision blurred—Doxorubicin—testicular cancer	7.1e-05	0.000285	CcSEcCtD
Moxifloxacin—Convulsion—Epirubicin—testicular cancer	7.06e-05	0.000283	CcSEcCtD
Moxifloxacin—Nausea—Etoposide—testicular cancer	7.05e-05	0.000283	CcSEcCtD
Moxifloxacin—Hypertension—Epirubicin—testicular cancer	7.03e-05	0.000282	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Doxorubicin—testicular cancer	6.99e-05	0.000281	CcSEcCtD
Moxifloxacin—Nervous system disorder—Methotrexate—testicular cancer	6.97e-05	0.00028	CcSEcCtD
Moxifloxacin—Anaemia—Doxorubicin—testicular cancer	6.97e-05	0.00028	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Methotrexate—testicular cancer	6.96e-05	0.000279	CcSEcCtD
Moxifloxacin—Myalgia—Epirubicin—testicular cancer	6.94e-05	0.000278	CcSEcCtD
Moxifloxacin—Arthralgia—Epirubicin—testicular cancer	6.94e-05	0.000278	CcSEcCtD
Moxifloxacin—Chest pain—Epirubicin—testicular cancer	6.94e-05	0.000278	CcSEcCtD
Moxifloxacin—Agitation—Doxorubicin—testicular cancer	6.93e-05	0.000278	CcSEcCtD
Moxifloxacin—Anxiety—Epirubicin—testicular cancer	6.91e-05	0.000277	CcSEcCtD
Moxifloxacin—Skin disorder—Methotrexate—testicular cancer	6.9e-05	0.000277	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	6.89e-05	0.000276	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Methotrexate—testicular cancer	6.87e-05	0.000276	CcSEcCtD
Moxifloxacin—Discomfort—Epirubicin—testicular cancer	6.85e-05	0.000275	CcSEcCtD
Moxifloxacin—Malaise—Doxorubicin—testicular cancer	6.8e-05	0.000273	CcSEcCtD
Moxifloxacin—Dry mouth—Epirubicin—testicular cancer	6.78e-05	0.000272	CcSEcCtD
Moxifloxacin—Vertigo—Doxorubicin—testicular cancer	6.77e-05	0.000272	CcSEcCtD
Moxifloxacin—Anorexia—Methotrexate—testicular cancer	6.77e-05	0.000272	CcSEcCtD
Moxifloxacin—Syncope—Doxorubicin—testicular cancer	6.76e-05	0.000271	CcSEcCtD
Moxifloxacin—Leukopenia—Doxorubicin—testicular cancer	6.75e-05	0.000271	CcSEcCtD
Moxifloxacin—Confusional state—Epirubicin—testicular cancer	6.7e-05	0.000269	CcSEcCtD
Moxifloxacin—Palpitations—Doxorubicin—testicular cancer	6.66e-05	0.000267	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Epirubicin—testicular cancer	6.65e-05	0.000267	CcSEcCtD
Moxifloxacin—Oedema—Epirubicin—testicular cancer	6.65e-05	0.000267	CcSEcCtD
Moxifloxacin—Hypotension—Methotrexate—testicular cancer	6.64e-05	0.000266	CcSEcCtD
Moxifloxacin—Loss of consciousness—Doxorubicin—testicular cancer	6.63e-05	0.000266	CcSEcCtD
Moxifloxacin—Cough—Doxorubicin—testicular cancer	6.58e-05	0.000264	CcSEcCtD
Moxifloxacin—Shock—Epirubicin—testicular cancer	6.54e-05	0.000262	CcSEcCtD
Moxifloxacin—Convulsion—Doxorubicin—testicular cancer	6.53e-05	0.000262	CcSEcCtD
Moxifloxacin—Nervous system disorder—Epirubicin—testicular cancer	6.52e-05	0.000262	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Epirubicin—testicular cancer	6.51e-05	0.000261	CcSEcCtD
Moxifloxacin—Hypertension—Doxorubicin—testicular cancer	6.51e-05	0.000261	CcSEcCtD
Moxifloxacin—Tachycardia—Epirubicin—testicular cancer	6.49e-05	0.00026	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Methotrexate—testicular cancer	6.47e-05	0.00026	CcSEcCtD
Moxifloxacin—Skin disorder—Epirubicin—testicular cancer	6.46e-05	0.000259	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Epirubicin—testicular cancer	6.43e-05	0.000258	CcSEcCtD
Moxifloxacin—Insomnia—Methotrexate—testicular cancer	6.43e-05	0.000258	CcSEcCtD
Moxifloxacin—Arthralgia—Doxorubicin—testicular cancer	6.42e-05	0.000257	CcSEcCtD
Moxifloxacin—Myalgia—Doxorubicin—testicular cancer	6.42e-05	0.000257	CcSEcCtD
Moxifloxacin—Chest pain—Doxorubicin—testicular cancer	6.42e-05	0.000257	CcSEcCtD
Moxifloxacin—Anxiety—Doxorubicin—testicular cancer	6.4e-05	0.000257	CcSEcCtD
Moxifloxacin—Paraesthesia—Methotrexate—testicular cancer	6.38e-05	0.000256	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	6.37e-05	0.000256	CcSEcCtD
Moxifloxacin—Discomfort—Doxorubicin—testicular cancer	6.34e-05	0.000254	CcSEcCtD
Moxifloxacin—Anorexia—Epirubicin—testicular cancer	6.34e-05	0.000254	CcSEcCtD
Moxifloxacin—Dyspnoea—Methotrexate—testicular cancer	6.33e-05	0.000254	CcSEcCtD
Moxifloxacin—Somnolence—Methotrexate—testicular cancer	6.32e-05	0.000253	CcSEcCtD
Moxifloxacin—Dry mouth—Doxorubicin—testicular cancer	6.28e-05	0.000252	CcSEcCtD
Moxifloxacin—Dyspepsia—Methotrexate—testicular cancer	6.25e-05	0.000251	CcSEcCtD
Moxifloxacin—Hypotension—Epirubicin—testicular cancer	6.21e-05	0.000249	CcSEcCtD
Moxifloxacin—Confusional state—Doxorubicin—testicular cancer	6.2e-05	0.000249	CcSEcCtD
Moxifloxacin—Decreased appetite—Methotrexate—testicular cancer	6.18e-05	0.000248	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Doxorubicin—testicular cancer	6.15e-05	0.000247	CcSEcCtD
Moxifloxacin—Oedema—Doxorubicin—testicular cancer	6.15e-05	0.000247	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Methotrexate—testicular cancer	6.13e-05	0.000246	CcSEcCtD
Moxifloxacin—Fatigue—Methotrexate—testicular cancer	6.13e-05	0.000246	CcSEcCtD
Moxifloxacin—Pain—Methotrexate—testicular cancer	6.08e-05	0.000244	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Epirubicin—testicular cancer	6.06e-05	0.000243	CcSEcCtD
Moxifloxacin—Shock—Doxorubicin—testicular cancer	6.05e-05	0.000243	CcSEcCtD
Moxifloxacin—Nervous system disorder—Doxorubicin—testicular cancer	6.03e-05	0.000242	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Doxorubicin—testicular cancer	6.02e-05	0.000242	CcSEcCtD
Moxifloxacin—Insomnia—Epirubicin—testicular cancer	6.01e-05	0.000241	CcSEcCtD
Moxifloxacin—Tachycardia—Doxorubicin—testicular cancer	6.01e-05	0.000241	CcSEcCtD
Moxifloxacin—Skin disorder—Doxorubicin—testicular cancer	5.98e-05	0.00024	CcSEcCtD
Moxifloxacin—Paraesthesia—Epirubicin—testicular cancer	5.97e-05	0.00024	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Doxorubicin—testicular cancer	5.95e-05	0.000239	CcSEcCtD
Moxifloxacin—Dyspnoea—Epirubicin—testicular cancer	5.93e-05	0.000238	CcSEcCtD
Moxifloxacin—Somnolence—Epirubicin—testicular cancer	5.91e-05	0.000237	CcSEcCtD
Moxifloxacin—Anorexia—Doxorubicin—testicular cancer	5.86e-05	0.000235	CcSEcCtD
Moxifloxacin—Feeling abnormal—Methotrexate—testicular cancer	5.86e-05	0.000235	CcSEcCtD
Moxifloxacin—Dyspepsia—Epirubicin—testicular cancer	5.85e-05	0.000235	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Methotrexate—testicular cancer	5.81e-05	0.000233	CcSEcCtD
Moxifloxacin—Decreased appetite—Epirubicin—testicular cancer	5.78e-05	0.000232	CcSEcCtD
Moxifloxacin—Hypotension—Doxorubicin—testicular cancer	5.75e-05	0.000231	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Epirubicin—testicular cancer	5.74e-05	0.00023	CcSEcCtD
Moxifloxacin—Fatigue—Epirubicin—testicular cancer	5.73e-05	0.00023	CcSEcCtD
Moxifloxacin—Pain—Epirubicin—testicular cancer	5.69e-05	0.000228	CcSEcCtD
Moxifloxacin—Constipation—Epirubicin—testicular cancer	5.69e-05	0.000228	CcSEcCtD
Moxifloxacin—Urticaria—Methotrexate—testicular cancer	5.64e-05	0.000226	CcSEcCtD
Moxifloxacin—Body temperature increased—Methotrexate—testicular cancer	5.62e-05	0.000225	CcSEcCtD
Moxifloxacin—Abdominal pain—Methotrexate—testicular cancer	5.62e-05	0.000225	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	5.61e-05	0.000225	CcSEcCtD
Moxifloxacin—Insomnia—Doxorubicin—testicular cancer	5.56e-05	0.000223	CcSEcCtD
Moxifloxacin—Paraesthesia—Doxorubicin—testicular cancer	5.52e-05	0.000222	CcSEcCtD
Moxifloxacin—Dyspnoea—Doxorubicin—testicular cancer	5.49e-05	0.00022	CcSEcCtD
Moxifloxacin—Feeling abnormal—Epirubicin—testicular cancer	5.48e-05	0.00022	CcSEcCtD
Moxifloxacin—Somnolence—Doxorubicin—testicular cancer	5.47e-05	0.000219	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Epirubicin—testicular cancer	5.44e-05	0.000218	CcSEcCtD
Moxifloxacin—Dyspepsia—Doxorubicin—testicular cancer	5.42e-05	0.000217	CcSEcCtD
Moxifloxacin—Decreased appetite—Doxorubicin—testicular cancer	5.35e-05	0.000215	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Doxorubicin—testicular cancer	5.31e-05	0.000213	CcSEcCtD
Moxifloxacin—Fatigue—Doxorubicin—testicular cancer	5.3e-05	0.000213	CcSEcCtD
Moxifloxacin—Urticaria—Epirubicin—testicular cancer	5.28e-05	0.000212	CcSEcCtD
Moxifloxacin—Pain—Doxorubicin—testicular cancer	5.26e-05	0.000211	CcSEcCtD
Moxifloxacin—Constipation—Doxorubicin—testicular cancer	5.26e-05	0.000211	CcSEcCtD
Moxifloxacin—Abdominal pain—Epirubicin—testicular cancer	5.26e-05	0.000211	CcSEcCtD
Moxifloxacin—Body temperature increased—Epirubicin—testicular cancer	5.26e-05	0.000211	CcSEcCtD
Moxifloxacin—Hypersensitivity—Methotrexate—testicular cancer	5.24e-05	0.00021	CcSEcCtD
Moxifloxacin—Asthenia—Methotrexate—testicular cancer	5.1e-05	0.000205	CcSEcCtD
Moxifloxacin—Feeling abnormal—Doxorubicin—testicular cancer	5.07e-05	0.000203	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Doxorubicin—testicular cancer	5.03e-05	0.000202	CcSEcCtD
Moxifloxacin—Pruritus—Methotrexate—testicular cancer	5.03e-05	0.000202	CcSEcCtD
Moxifloxacin—Hypersensitivity—Epirubicin—testicular cancer	4.9e-05	0.000197	CcSEcCtD
Moxifloxacin—Urticaria—Doxorubicin—testicular cancer	4.89e-05	0.000196	CcSEcCtD
Moxifloxacin—Abdominal pain—Doxorubicin—testicular cancer	4.86e-05	0.000195	CcSEcCtD
Moxifloxacin—Body temperature increased—Doxorubicin—testicular cancer	4.86e-05	0.000195	CcSEcCtD
Moxifloxacin—Diarrhoea—Methotrexate—testicular cancer	4.86e-05	0.000195	CcSEcCtD
Moxifloxacin—Asthenia—Epirubicin—testicular cancer	4.77e-05	0.000191	CcSEcCtD
Moxifloxacin—Pruritus—Epirubicin—testicular cancer	4.7e-05	0.000189	CcSEcCtD
Moxifloxacin—Dizziness—Methotrexate—testicular cancer	4.7e-05	0.000189	CcSEcCtD
Moxifloxacin—Diarrhoea—Epirubicin—testicular cancer	4.55e-05	0.000183	CcSEcCtD
Moxifloxacin—Hypersensitivity—Doxorubicin—testicular cancer	4.53e-05	0.000182	CcSEcCtD
Moxifloxacin—Vomiting—Methotrexate—testicular cancer	4.52e-05	0.000181	CcSEcCtD
Moxifloxacin—Rash—Methotrexate—testicular cancer	4.48e-05	0.00018	CcSEcCtD
Moxifloxacin—Dermatitis—Methotrexate—testicular cancer	4.48e-05	0.00018	CcSEcCtD
Moxifloxacin—Headache—Methotrexate—testicular cancer	4.45e-05	0.000179	CcSEcCtD
Moxifloxacin—Asthenia—Doxorubicin—testicular cancer	4.41e-05	0.000177	CcSEcCtD
Moxifloxacin—Dizziness—Epirubicin—testicular cancer	4.4e-05	0.000176	CcSEcCtD
Moxifloxacin—Pruritus—Doxorubicin—testicular cancer	4.35e-05	0.000175	CcSEcCtD
Moxifloxacin—Vomiting—Epirubicin—testicular cancer	4.23e-05	0.00017	CcSEcCtD
Moxifloxacin—Nausea—Methotrexate—testicular cancer	4.22e-05	0.000169	CcSEcCtD
Moxifloxacin—Diarrhoea—Doxorubicin—testicular cancer	4.21e-05	0.000169	CcSEcCtD
Moxifloxacin—Rash—Epirubicin—testicular cancer	4.19e-05	0.000168	CcSEcCtD
Moxifloxacin—Dermatitis—Epirubicin—testicular cancer	4.19e-05	0.000168	CcSEcCtD
Moxifloxacin—Headache—Epirubicin—testicular cancer	4.17e-05	0.000167	CcSEcCtD
Moxifloxacin—Dizziness—Doxorubicin—testicular cancer	4.07e-05	0.000163	CcSEcCtD
Moxifloxacin—Nausea—Epirubicin—testicular cancer	3.95e-05	0.000158	CcSEcCtD
Moxifloxacin—Vomiting—Doxorubicin—testicular cancer	3.91e-05	0.000157	CcSEcCtD
Moxifloxacin—Rash—Doxorubicin—testicular cancer	3.88e-05	0.000156	CcSEcCtD
Moxifloxacin—Dermatitis—Doxorubicin—testicular cancer	3.88e-05	0.000155	CcSEcCtD
Moxifloxacin—Headache—Doxorubicin—testicular cancer	3.85e-05	0.000155	CcSEcCtD
Moxifloxacin—Nausea—Doxorubicin—testicular cancer	3.65e-05	0.000147	CcSEcCtD
